Preview Mode Links will not work in preview mode

May 17, 2022

Featuring perspectives from Ms Jamie Carroll, Dr Sara Hurvitz, Ms Kelly Leonard and Dr Hope Rugo, including the following topics:

  • Introduction (0:00)
  • High-Risk Localized ER-Positive, HER2-Negative Breast Cancer (5:07)
  • ER-Positive Metastatic Breast Cancer (28:06)
  • Localized HER2-Positive Breast Cancer (49:15)
  • Metastatic HER2-Positive Breast Cancer (1:07:06)
  • Localized Triple-Negative Breast Cancer (TNBC); Role of Immunotherapy (1:30:08)
  • Metastatic TNBC (1:49:41)

CME information and select publications